Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an...

por Duska, Linda R., Java, James J., Cohn, David E., Burger, Robert A.
Publicado en Gynecol Oncol (2015)

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2

por Bishop, Erin A., Java, James J., Moore, Kathleen N., Walker, Joan L.
Publicado en Int J Gynecol Cancer (2017)

Mixed-methods content and sentiment analysis of adolescents’ voice-diaries describing daily experiences with asthma and self-management decision-making

por Mammen, Jennifer R., Java, James J., Rhee, Hyekyun, Butz, Arlene M., Halterman, Jill S., Arcoleo, Kimberly
Publicado en Clin Exp Allergy (2018)

Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-base...

por Rose, Peter G, Java, James J, Whitney, Charles W., Stehman, Frederick B, Lanciano, Rachelle, Thomas, Gillian M
Publicado en Gynecol Oncol (2014)

The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group tr...

por Chan, John K., Java, James J., Fuh, Katherine, Monk, Bradley J., Kapp, Daniel S., Herzog, Thomas, Bell, Jeffrey, Young, Robert
Publicado en Gynecol Oncol (2016)

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

por Tewari, Devansu, Java, James J., Salani, Ritu, Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas, Monk, Bradley J., Chan, John K.
Publicado en J Clin Oncol (2015)

Disease Extent at Secondary Cytoreductive Surgery is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Grou...

por Rose, Peter G., Java, James J., Morgan, Mark A., Secord, Angeles Alvarez, Kesterson, Joshua P., Stehman, Frederick B., Warshal, David P., Creasman, William T., Hanjani, Parviz, Morris, Robert T., Copeland, Larry J.
Publicado en Gynecol Oncol (2016)

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

por Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Publicado en Gynecol Oncol (2015)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

por Seamon, Leigh G, Java, James J, Monk, Bradley J, Penson, Richard T, Brown, Jubilee, Mannel, Robert S, Oaknin, Anna, Leitao, Mario M, Eisenhauer, Eric L, Long, Harry J, Liao, Shu Y, Tewari, Krishnansu S
Publicado en Br J Cancer (2018)

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group...

por Garcia-Soto, Arlene E, Java, James J, Neira, Wilberto Nieves, Pearson, J Matthew, Cohn, David E., Lele, Shashikant B, Tewari, Krishnansu S, Walker, Joan L, Secord, Angeles Alvarez, Armstrong, Deborah K, Copeland, Larry J
Publicado en Gynecol Oncol (2016)

Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Stud...

por Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O’Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Publicado en Gynecol Oncol (2018)

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Onc...

por Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O'Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Publicado en Gynecol Oncol (2018)

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data...

por Moore, Kathleen N., Java, James J., Slaughter, Katrina N., Rose, Peter G., Lanciano, Rachelle, DiSilvestro, Paul A., Thigpen, J. Tate, Lee, Yi-Chun, Tewari, Krishnansu S., Chino, Junzo, Seward, Shelly M., Miller, David S., Salani, Ritu, Moore, David H., Stehman, Frederick B.
Publicado en Gynecol Oncol (2016)

Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study

por Bishop, Erin A., Java, James J., Moore, Kathleen N., Spirtos, Nick M, Pearl, Michael L, Zivanovic, Oliver, Kushner, David M, Backes, Floor, Hamilton, Chad A., Geller, Melissa A., Hurteau, Jean, Mathews, Cara, Wenham, Robert M., Ramirez, Pedro T., Zweizig, Susan, Walker, Joan L.
Publicado en Am J Obstet Gynecol (2017)

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients()

por Fuh, Katherine C., Java, James J., Chan, John K., Kapp, Daniel S., Monk, Bradley J., Burger, Robert A., Young, Robert C., Alberts, David S., McGuire, William P., Markman, Maurie, Bell, Jeffrey, Ozols, Robert F., Armstrong, Deborah K., Aghajanian, Carol, Bookman, Michael A., Mannel, Robert S.
Publicado en Gynecol Oncol (2019)

Predictive Modeling for Determination of Microscopic Residual Disease at Primary Cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

por Horowitz, Neil S., Maxwell, G. Larry, Miller, Austin, Hamilton, Chad A., Rungruang, Bunja, Rodriguez, Noah, Richard, Scott D., Krivak, Thomas C., Fowler, Jeffrey M., Mutch, David G., Van Le, Linda, Lee, Roger B., Argenta, Peter, Bender, David, Tewari, Krishnansu S., Gershenson, David, Java, James J., Bookman, Michael A.
Publicado en Gynecol Oncol (2017)

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma

por Rose, Peter G, Java, James J, Salani, Ritu, Geller, Melissa A, Alvarez, Angeles, Tewari, Krishnansu S, Bender, David P, Mutch, David G, Friedlander, Michael L, Van Le, Linda, Method, Michael W, Hamilton, Chad A, Lee, Roger B, Wenham, Robert M, Guntupalli, Saketh R, Markman, Maurie, Muggia, Franco M, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Copeland, Larry J
Publicado en Obstet Gynecol (2019)